1st Personalized Cancer Care for Dogs

Why Offer FidoCure© to Families Fighting Canine Cancer?

Dr. Gerald Post 
DVM MEM DACVIM Founder, Veterinary Cancer Center & Animal Cancer Foundation; 
OneHealth Chief Veterinary Officer

Expand Your Cancer Treatment Toolbox


Personalized medicine, precision medicine and theranostics are synonymous terms. Each refers to the practice of medicine whereby the patient’s medical decisions are individualized. With respect to drug interventions, this means targeting treatments to the individual patient based on their predicted response to those therapies. In human oncology, targeted therapies are now used in most indications.


The One Health Company is the first and only company to bring personalized medicine to canine cancer care. Our FidoCure© offering consists of genetic testing intended to identify the mutation driving cancerdiagnostic and treatment information. The veterinarian can then prescribe targeted therapies (oral) if they are potentially beneficial for their patients, via a compounding pharmacy.



Cutting-Edge Oncology Care

Traditional Canine Cancer Treatment

One size fits all approach

FidoCure Approach

Genetic information used
to get the precise medicine



The options to treat canine cancer are often limited, while pet parents are increasingly willing to do more for their dogs. FidoCure© enables veterinarians to differentiate their practice with advanced, personalized canine cancer care, previously only available for humans.

Human Oncology

1.6M New Annual Cases

70+ Targeted Therapies in use

Veterinary Oncology

6M New Annual Cases

˜1 Targeted Therapy in use

Patient Well-Being: Rigorous Criteria


Patient Well Being is our Highest Commitment​​

  • Our DNA test is run in a CLIA certified lab  

  • Deep Database of known toxicity profiles for canines and NOAEL for human FDA approved therapies

How It Works

Genomic Test for Dogs

DNA NGS Panel + RNA Gene Expression Profiling

  • Submit your case on our online portal to get started

  • Send us your patient’s tissue

  • We run your patient’s DNA & RNA profiling

Personalized Patient Report + Support

Actionable tumor genomic profiling results + Support for Clinician

  • We send you the genomic results & personalized targeted therapies implications for your patient

  • Schedule a consultation with our expert veterinary oncologists 

  • Evaluate results and decide the best treatment plan for your patient

Access Treatment Options


  • If the veterinarian feels this is a good option for their patient, the clinician can prescribes and orders from the compounding pharmacy. 

  • The veterinarian chooses if therapies are shipped to their clinic or patient's home.

DISCLAIMER: FidoCure™ is a leader in oncology research for dogs, and our team is committed to the breakthroughs in cancer biology to evolve canine cancer care, with each patient improving the outcomes for all future canine cancer patients. We use our best efforts to inform the veterinarian, who then decides which option is best for their patient. The therapies that veterinarians may prescribe and order from compounding pharmacies after receiving genetic test results from FidoCure, may constitute extra-label uses of those drugs. FidoCure is continuing to gather research data in support of novel oncology therapeutics in dogs.

  • Instagram - White Circle
  • Twitter - White Circle
  • Facebook - White Circle

© One Health Company 2019